Ambarella Inc: Form 10-Q for the period ended Jul 31, 2025
Filed with the SEC on Sep 3, 2025 and accepted by EDGAR at Sep 3, 2025, 14:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-05-01 to 2025-07-31 | $95.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-02-01 to 2025-07-31 | $181.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-05-01 to 2025-07-31 | $39.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-02-01 to 2025-07-31 | $73.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-05-01 to 2025-07-31 | $56.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2025-02-01 to 2025-07-31 | $107.8m | us-gaap:GrossProfit |
| Research and development | 3 months2025-05-01 to 2025-07-31 | $59.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-02-01 to 2025-07-31 | $118.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-05-01 to 2025-07-31 | $18.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-02-01 to 2025-07-31 | $37.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-05-01 to 2025-07-31 | −$22.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-02-01 to 2025-07-31 | −$47.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-05-01 to 2025-07-31 | $253.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-02-01 to 2025-07-31 | $898.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-05-01 to 2025-07-31 | −$20.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-02-01 to 2025-07-31 | −$44.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-05-01 to 2025-07-31 | −$0.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-02-01 to 2025-07-31 | −$1.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-05-01 to 2025-07-31 | −$0.47 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-02-01 to 2025-07-31 | −$1.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-05-01 to 2025-07-31 | 42,546,979 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-02-01 to 2025-07-31 | 42,383,475 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-02-01 to 2025-07-31 | $20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-02-01 to 2025-07-31 | $8.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 6 months2025-02-01 to 2025-07-31 | $1.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-07-31 | $142.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-07-31 | $343.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-07-31 | $706.4m | us-gaap:Assets |
| Current liabilities | At period end2025-07-31 | $125.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-07-31 | $129.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-07-31 | $576.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-25-194853. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.